Yuchuan Gong

USPTO Granted Patents = 18 (Patent Applications = 13)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 381(Granted Patents)

Location History:

Waukegan, IL (US) (2013 - 2022)
North Chicago, IL (US) (2024)

Company Filing History:

Vertex Pharmaceuticals, Inc.

patents

1 out of 120

Neurocrine Biosciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12083227 - Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis (2024-09-10),

2. 11291662 - Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2022-04-05),

3. 10730873 - Salts and crystalline forms of an apoptosis-inducing agent (2020-08-04),

4. 10537565 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2020-01-21),

5. 9931334 - Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2018-04-03),

6. 9840502 - Salts and crystalline forms of an apoptosis-inducing agent (2017-12-12),

7. 9670163 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2017-06-06),

8. 9637476 - Atrasentan mandelate salts (2017-05-02),

9. 9469673 - Crystaline forms of HCV inhibitor (2016-10-18),

10. 9321765 - Crystalline bromodomain inhibitors (2016-04-26),

11. 9238649 - Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (2016-01-19),

12. 9174944 - Crystalline lopinavir/surfactant adducts (2015-11-03),

13. 9139530 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2015-09-22),

14. 8962675 - Atrasentan mandelate salts (2015-02-24),

15. 8754224 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2014-06-17),

Title: Inventor Yuchuan Gong: A Pioneer in Pharmaceutical Innovations

Introduction

Yuchuan Gong is a notable inventor based in Waukegan, Illinois, who has significantly contributed to the field of pharmaceuticals. With an impressive portfolio of 18 patents, his work primarily focuses on innovative treatments for various women's health issues.

Latest Patents

Among his latest patents, two stand out for their advancements in pharmaceutical formulations. The first is a patent for solid pharmaceutical formulations intended for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome, and adenomyosis. This innovation involves pharmaceutical compositions that include a gonadotropin-releasing hormone (GnRH) antagonist, along with methods for preparing and utilizing these compositions. The second patent relates to solid-state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, highlighting the importance of pharmaceutical compositions and their associated methods.

Career Highlights

Throughout his career, Yuchuan Gong has made significant impacts while working with prominent companies including AbbVie Inc. and Vertex Pharmaceuticals, Inc. His role in these organizations has allowed him to push the boundaries of pharmaceutical research and development.

Collaborations

Yuchuan has collaborated with notable colleagues such as Geoff G. Zhang and Patricia Nell Hurter. These collaborations have contributed to the advancements in pharmaceutical innovations and the enhancement of drug therapies aimed at improving patient outcomes.

Conclusion

Yuchuan Gong's dedication and contributions to the pharmaceutical industry are exemplified by his numerous patents and collaborations. His work, particularly on compounds targeting women's health issues, showcases the innovative spirit that drives progress in medical treatments. As he continues to develop groundbreaking solutions, Yuchuan Gong remains a key figure among inventors in the realm of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.